Skip to main content
RNXT logo
RNXT
(NASDAQ)
RenovoRx, Inc.
$0.85-- (--)
Loading... - Market loading

RenovoRx (RNXT) Stock Price & Financial Analysis

RenovoRx Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.85 - $0.87
52-Week High$1.45
52-Week Low$0.70
Open$0.86
Volume72.74K
Average Volume (3M)195.67K
Market Cap32.50M
Shares Outstanding38.03M
Price to Sales (P/S)21.83
Price to Book (P/B)2.88
EV/EBITDA-1.57
Revenue (TTM)1.49M
Net Income (TTM)-12.27M
Free Cash Flow (TTM)-11.30M
EPS (TTM)$-0.33
Profit Margin-823.98%
Operating Margin-864.34%
Return on Equity (ROE)-108.91%
Debt to Equity0.02
50-Day MA$0.89
200-Day MA$0.95
52-Week Change-32.72%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About RenovoRx

What is the current stock price for RNXT?

As of the latest trading session, RNXT stock trades at $0.85. The 52-week range is $0.70–$1.45, with a day range of $0.85–$0.87.

What is the P/E ratio for RNXT?

The P/E ratio (Price-to-Earnings) for RNXT is shown in the Key Statistics section. This valuation metric helps compare RenovoRx, Inc. to industry peers.

Does RNXT pay dividends?

RenovoRx does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RNXT?

Analyst ratings and recommendations for RNXT are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of RNXT?

RenovoRx's market capitalization is $32.5M, classifying it as a micro-cap company. RenovoRx operates in the Healthcare sector within the Biotechnology industry.